Medicine

Mounjaro, Zepbound users gained strength with weight training, study finds

Adults receiving the drug used in Mounjaro and Zepbound lost less lean tissue when they added three weekly resistance sessions.

Weight loss.
Healthcare technology innovations.

Israel’s healthcare technology sector and emerging innovations

Medical robot

Israeli study shows success of robotic surgery in repairing complicated abdominal hernias

An illustrative image of AI chatbots and medical assistants for digital health consultations and online medical support.

Can AI tell when patients don't need medical tests? Israeli study puts chatbots to the test


The Israeli drug that will revolutionize treatment for diabetes patients worldwide

Diabetes patients, among others, suffer from chronic wounds that do not heal, which sometimes end in limb amputations. An Israeli drug intends to change the situation.

A problem affecting millions of patients worldwide. Chronic wounds that fail to heal.

Turpaz CEO donates NIS 70 million to three of Israel’s leading hospitals

During the ceremony, Sheba inaugurated its Institute for Obstetric and Gynecologic Imaging in memory of Cohen Khazon’s late parents, Nediva (Gisèle) and Moshe (Musa) Cohen.

Ribbon-cutting ceremony at  Sheba’s Institute for Gynecological and Obstetric Ultrasound.

Man receives human kidney transplant after surviving 271 days with gene-edited pig organ

Andrews was 66, had end-stage kidney disease, no suitable living donor, and a long anticipated wait time for a deceased donor when he underwent surgery in 2025 to receive a kidney from a pig.

Medical team performing surgery

Israel must fight harder to keep its doctors in the country - editorial

Israel needs doctors. There are Jewish doctors around the world who may want to make Israel their home. Connecting the two is vital for a country that prides itself on solving difficult problems.

Israeli doctors perform cardiac catheterizations at Hadassah Ein Karem Hospital, in Jerusalem, on January 20, 2020.

Brain drain: Israel’s medical exodus grows as nearly 1,400 doctors leave inside three years

In 2023, 416 doctors left Israel for at least one year, compared with 530 in 2024 and a preliminary estimate of 419 in 2025.

Doctors at Shaare Zedek in Jerusalem; illustrative.

Fighting two cancers: Amir Heshmatpour’s battle against brain tumors and Iran’s regime - interview

A Persian entrepreneur with a Jewish wife, a breakthrough brain-cancer drug, and a mission against Tehran. NeOnc's Amir Heshmatpour, in his own words.

'Iran is a cancer': Iranian-born CEO takes on the regime

Targeted antibiotic gel helps 80% of pilot patients avoid foot amputation, Jerusalem trial finds

GentaGel’s biodegradable treatment releases antibiotics directly at infection sites for up to 60 days; the company is pursuing further trials and an FDA regulatory pathway.

Dr. Ariel Orbach (L), Co-Founder and CEO of GentaGel, Prof. Avi Domb (M), Inventor of GentaGel-LR Technology, and Eli Lerner (R), Co-founder and COO of GentaGel.

Medical coexistence: Arab Israeli doctors show the cost of Israel’s medical school shortage

As Israel faces a growing doctor shortage, Arab Israelis now make up 25% of physicians and play an essential role in a health system that also offers a model of coexistence.

TODAY, 25% of the country’s working physicians are Arab-Israeli.

Revolution Medicines gets FDA approval for targeted pancreatic cancer drug

Revolution said the drug is now available in the United States at $39,800 for a 30-day supply. The company added that it would make assistance available as well.

Menta "Steve" Wallace shows a bottle of daraxonrasib, Revolution Medicine?s pancreatic cancer drug, at his home in The Woodlands, Texas, U.S., May 29, 2026.

Dozens of cardiologists may have skipped internal medicine training, falsified records - report

According to a Channel 13 report, the committee was formed after a resident doctor at the center alleged that residency logs had been falsified so cardiology residents could skip the training.

View of the Kaplan Medical Center in Rehovot. January 26, 2026.